Morphic Holding, Inc. NASDAQ:MORF

Founder-led company
Financial Health
0
1
2
3
4
5
6
7
8
9

Morphic Holding stock price monthly change

+93.95%
month

Morphic Holding stock price quarterly change

+85.25%
quarter

Morphic Holding stock price yearly change

-8.02%
year

Morphic Holding key metrics

Market Cap
2.86B
Enterprise value
1.29B
P/E
-22.51
EV/Sales
18.35
EV/EBITDA
-24.34
Price/Sales
19.14
Price/Book
3.88
PEG ratio
-0.53
EPS
-3.38
Revenue
N/A
EBITDA
-192.52M
Income
-161.25M
Revenue Q/Q
-100%
Revenue Y/Y
-100%
Profit margin
-83.38%
Oper. margin
-89.53%
Gross margin
0%
EBIT margin
-89.53%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Morphic Holding stock price history

Morphic Holding stock forecast

Morphic Holding financial statements

Morphic Holding, Inc. (NASDAQ:MORF): Profit margin
Jun 2023 60.23M -39.01M -64.77%
Sep 2023 0 -36.21M
Dec 2023 -60.23M -40.73M 67.63%
Mar 2024 0 -45.29M
Morphic Holding, Inc. (NASDAQ:MORF): Analyst Estimates
2025 750K -228.78M -30505.09%
2026 857.14K -250.07M -29175.16%
2027 1.5M -210.85M -14056.71%
2028 153.45M -145.06M -94.53%
  • Analysts Price target

  • Financials & Ratios estimates

Morphic Holding, Inc. (NASDAQ:MORF): Debt to assets
Jun 2023 748720000 19.35M 2.59%
Sep 2023 743602000 20.43M 2.75%
Dec 2023 722514000 25.49M 3.53%
Mar 2024 682765000 19.18M 2.81%
Morphic Holding, Inc. (NASDAQ:MORF): Cash Flow
Jun 2023 -23.03M -133.21M 331.62M
Sep 2023 -29.25M -133.08M 19.28M
Dec 2023 -28.57M 12.88M 34K
Mar 2024 -46.38M 31.36M 911K

Morphic Holding alternative data

Morphic Holding, Inc. (NASDAQ:MORF): Employee count
Aug 2023 107
Sep 2023 110
Oct 2023 110
Nov 2023 110
Dec 2023 115
Jan 2024 115
Feb 2024 115
Mar 2024 121
Apr 2024 121
May 2024 124
Jun 2024 124
Jul 2024 124

Morphic Holding other data

38.04% -42.42%
of MORF is owned by hedge funds
14.49M -16.47M
shares is hold by hedge funds

Morphic Holding, Inc. (NASDAQ:MORF): Insider trades (number of shares)
Period Buy Sel
Sep 2023 0 20000
Nov 2023 4776 0
Jan 2024 0 35876
Jul 2024 0 125790
Transaction Date Insider Security Shares Price per share Total value Source
Sale
SCHEGERIN MARC officer: CFO and COO
Common Stock 43,936 $55.8 $2,451,629
Option
SCHEGERIN MARC officer: CFO and COO
Employee Stock Option (right to buy) 43,936 $15 $659,040
Option
TIPIRNENI PRAVEEN P. director, officer.. Employee Stock Option (right to buy) 21,582 $4.32 $93,126
Option
TIPIRNENI PRAVEEN P. director, officer.. Common Stock 21,582 $4.32 $93,126
Sale
TIPIRNENI PRAVEEN P. director, officer.. Common Stock 21,582 $55.79 $1,204,081
Option
ROGERS BRUCE officer: PRESIDENT
Common Stock 20,000 $4.32 $86,300
Option
FARRELL ROBERT E JR officer: SVP Finance and CAO
Employee Stock Option (right to buy) 8,786 $4.32 $37,912
Option
DEVAUL WILLIAM officer: General Counsel and Se..
Employee Stock Option (right to buy) 10,000 $4.32 $43,150
Option
DEVAUL WILLIAM officer: General Counsel and Se..
Common Stock 10,000 $4.32 $43,150
Sale
DEVAUL WILLIAM officer: General Counsel and Se..
Common Stock 10,000 $55.79 $557,910
Insider Compensation
Dr. Praveen P. Tipirneni M.D. (1968) Chief Executive Officer, Pres & Director $936,320
Dr. Marc Schegerin M.B.A., M.D. (1976) Chief Financial Officer & Chief Operating Officer
$597,090
Dr. Timothy A. Springer Ph.D. (1948) Founder, Independent Director & Member of Scientific Advisory Board $35,000
Friday, 16 August 2024
prnewswire.com
Monday, 12 August 2024
investopedia.com
Sunday, 11 August 2024
accesswire.com
Friday, 9 August 2024
accesswire.com
Thursday, 8 August 2024
globenewswire.com
accesswire.com
Wednesday, 7 August 2024
accesswire.com
Tuesday, 6 August 2024
accesswire.com
Monday, 5 August 2024
accesswire.com
Sunday, 4 August 2024
accesswire.com
Friday, 2 August 2024
globenewswire.com
accesswire.com
Thursday, 1 August 2024
accesswire.com
Wednesday, 31 July 2024
accesswire.com
globenewswire.com
Tuesday, 30 July 2024
accesswire.com
Monday, 29 July 2024
businesswire.com
accesswire.com
Sunday, 28 July 2024
globenewswire.com
accesswire.com
Friday, 26 July 2024
accesswire.com
Tuesday, 23 July 2024
prnewswire.com
Saturday, 20 July 2024
globenewswire.com
Friday, 19 July 2024
globenewswire.com
Thursday, 11 July 2024
globenewswire.com
Tuesday, 9 July 2024
businesswire.com
prnewswire.com
Monday, 8 July 2024
youtube.com
youtube.com
investorplace.com
  • When is Morphic Holding's next earnings date?

    Unfortunately, Morphic Holding's (MORF) next earnings date is currently unknown.

  • Does Morphic Holding pay dividends?

    No, Morphic Holding does not pay dividends.

  • How much money does Morphic Holding make?

    Morphic Holding has a market capitalization of 2.86B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 99.26% to 521K US dollars.

  • What is Morphic Holding's stock symbol?

    Morphic Holding, Inc. is traded on the NASDAQ under the ticker symbol "MORF".

  • What is Morphic Holding's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Morphic Holding?

    Shares of Morphic Holding can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Morphic Holding's key executives?

    Morphic Holding's management team includes the following people:

    • Dr. Praveen P. Tipirneni M.D. Chief Executive Officer, Pres & Director(age: 57, pay: $936,320)
    • Dr. Marc Schegerin M.B.A., M.D. Chief Financial Officer & Chief Operating Officer(age: 49, pay: $597,090)
    • Dr. Timothy A. Springer Ph.D. Founder, Independent Director & Member of Scientific Advisory Board(age: 77, pay: $35,000)
  • Is Morphic Holding founder-led company?

    Yes, Morphic Holding is a company led by its founder Dr. Timothy A. Springer Ph.D..

  • How many employees does Morphic Holding have?

    As Jul 2024, Morphic Holding employs 124 workers, which is 2% more then previous quarter.

  • When Morphic Holding went public?

    Morphic Holding, Inc. is publicly traded company for more then 6 years since IPO on 27 Jun 2019.

  • What is Morphic Holding's official website?

    The official website for Morphic Holding is morphictx.com.

  • Where are Morphic Holding's headquarters?

    Morphic Holding is headquartered at 35 Gatehouse Drive, A2, Waltham, MA.

  • How can i contact Morphic Holding?

    Morphic Holding's mailing address is 35 Gatehouse Drive, A2, Waltham, MA and company can be reached via phone at +7 819960955.

Morphic Holding company profile:

Morphic Holding, Inc.

morphictx.com
Exchange:

NASDAQ

Full time employees:

128

Industry:

Biotechnology

Sector:

Healthcare

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß6 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

35 Gatehouse Drive, A2
Waltham, MA 02451

CIK: 0001679363
ISIN: US61775R1059
CUSIP: 61775R105